COVID-19’s Achilles’ Heel, Other News From the Bio-IT Community

Bio-IT World | The Bio-IT community is continuing to adapt to their newfound role in the fight against the COVID-19 virus. Recent updates include recent collaborations between organizations and universities, innovative modeling tools, and the discovery that the virus’ main protease may wind up being its Achilles’ heel.

MilliporeSigma, 10x Genomics Launch New Option For CRISPR Research

Bio-IT World News Brief | MilliporeSigma and 10x Genomics announced that they have developed a new option for biological experiments. The collaboration provides a linking of two innovative technologies: single cell transcriptomics and pooled CRISPR screening.

COVID-19 Update: Structural Modeling, New Funding, Vaccine News

Bio-IT World | More updates on SARS-CoV-2 research and COVID-19 from the Bio-IT Community including an app to create COVID-19 severity scores, new insights into viral behavior, modeling tools for the virus structure, and an influx of funding from Illumina, the Department of Defense, AstraZeneca, and more.

10x Genomics: Culture of Collaboration And A New Product Engine

Bio-IT World | At 10x Genomics—where the vision is to “master biology”—culture is key.

Studies Suggest COVID-19 Could Become Seasonal Virus, Other News

Bio-IT World | A review of coronavirus immunity studies suggest the COVID-19 virus could become the fifth seasonal coronavirus with recurring epidemics of lessening severity over the next several years. Over 200 SARS-CoV-2 genome sequences have now been completed and released. We round up the week’s research and industry news for COVID-19.

Intel, Penn Medicine Launch Federated Learning Model For Brain Tumors

Bio-IT World | The University of Pennsylvania and Intel have built a federation of 30 institutions to use federated learning to train artificial intelligence models to identify boundaries of brain tumors.

Benchling, BERG, Thermo Fisher Scientific, And More: News From May 2020

Bio-IT World May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Benchling, BERG, Thermo Fisher Scientific, and more.

HPC In Life Sciences: Why Cloud Computing Is Now Indispensable And How Organizations Can Prepare

Bio-IT World Contributed Commentary | Few disciplines have seen more rapid adoption of cloud computing than life sciences research. Datasets are easily anonymized; pipelines are generally comprised of cloud-friendly open-source tools, and data are often shared, making the cloud a convenient meeting point. Overshadowing all of these reasons, however, is an insatiable demand for computing power.

AI Applications for COVID-19 Research and Other News

Bio-IT World | A pair of studies demonstrate antibody responses to COVID-19 in primates. Researchers are applying artificial intelligence to lung images of COVID-19 patients. An accurate, easy-to-use, fully disposable, rapid and handheld test that consumers and healthcare providers in clinics can use to detect active SARS-CoV-2. We round up the week’s research and industry news for COVID-19.

How Data Integration Can Save Lives and Economies During Pandemics

Bio-IT World Contributed Commentary | Advances in medicine, aided by technology, have saved many lives, no doubt. Credit can be given to many technologies, but when a new kind of viral disease comes along such as COVID-19, we are once again humbled.

What We’re Discovering About Scientific Computing During A Pandemic

Bio-IT Industry Continuing To Gain Insight On COVID-19, And Other News

Bio-IT World | A genome in pangolins could reveal a treatment option for COVID-19. A lack amount MicroRNA may explain why older individuals and those with preexisting medical conditions are vulnerable for contracting the virus. We round up the week’s research and industry news for COVID-19.

NVIDIA Announces New GPU Architecture, AI Compute System, Genomics Analysis Record, Smart Hospital Platform, More

Bio-IT World | NVIDIA moved its Graphics Technology Conference keynote online today. CEO Jensen Huang hosted the company’s first “kitchen keynote” with hardware laid out on the kitchen counter among spatulas and pepper mills. In the life sciences, NVIDIA announced the first DGX A100 installation, a speed record for genomics analysis from NVIDIA Clara Parabricks computational genomics software, the new NVIDIA Clara Guardian healthcare platform, and AI models for COVID-19.

Trends From The Socially Distanced Trenches: Storage, Image Analysis, And What’s Coming For Bio-IT

Bio-IT World | The 10^th anniversary of Chris Dagdigian’s Trends from the Trenches presentation kicked off yesterday to hundreds of audience members in attendance—but this time virtually.

Eli Dart On Science DMZs, COVID-19, And The Future Of Computing Infrastructure

Bio-IT World | TRENDS FROM THE TRENCHES—At the Energy Sciences Network—ESNet—Eli Dart works to help scientists, science collaborations, and facilities more effectively use high performance networking in the conduct of science. He talks with BioTeam's Stan Gloss on the future of networks.

Gene Therapy Company Dyno Therapeutics Pairs Biology With AI For Therapeutic Gains

Bio-IT World | Dyno Therapeutics emerged from stealth mode today and announced partnerships with Novartis and Sarepta Therapeutics to develop gene therapies for eye disease and neuromuscular and cardiovascular disease.

AI Predicts New COVID-19 Drugs, New Commercial COVID-19 Command Center

Bio-IT World   New research on COVID-19 treatments and vaccines from worldwide researchers at Northwestern University, Erasmus MC University Medical Center, the Russian Academy of Sciences, the University of Southern California and more. Saama Technologies and iNDX.Ai and launched the COVID-19 Command Center, and AI and supercomputing technologies flag new drugs. We round up the week’s research and industry news for COVID-19.

Lessons From Personalized Medicine Can Supercharge Coronavirus Testing

Bio-IT World Contributed Commentary | Months into the Covid-19 pandemic, the United States remains dangerously behind on testing—and we know that technology from personalized medicine can help correct the chaos.

GRAIL Founder Returns To Illumina As CTO

Bio-IT World | Illumina today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic.

Follow the Money: New European Fund, All-Flash Storage, More

Bio-IT World | New life sciences fund closes in Europe, big investments in VAST Data’s all flash storage, AI-written code, Lifebit’s CloudOS, Scopio Labs’s digital microscopy, microbiome tests and much more.